BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, December 27, 2025
Home » Newsletters » BioWorld MedTech

BioWorld MedTech

Aug. 7, 2020

View Archived Issues
business-strategy-development.png

Bausch Health to spin off eye health biz as publicly traded company Bausch + Lomb

Bausch Health Companies Inc. has long been considering strategic options for its eye health business. But now that it has paid down $8 billion in debt and divested $4 billion in non-core assets, it expects that the time is now right to spin out the eye health business as a separate publicly traded entity. Read More
Product image

Ginger secures $50M to expand mental health platform solutions

On-demand mental health company Ginger.io scooped up $50 million in a series D round that was led by Advance Venture Partners and Bessemer Venture Partners. Participants also included Cigna Ventures and existing investors such as Jeff Weiner, executive chairman of Linkedin, and Kaiser Permanente Venture. Read More
Coronavirus vs US

Harvard’s Mina says ‘archaic view’ of testing impeding cheap surveillance testing for COVID-19

The COVID-19 pandemic has sparked some innovation in testing, but not all that innovation has made it to market. Michael Mina, an assistant professor of epidemiology at the Chan School of Public Health at Harvard University, said on an Aug. 7 conference call that the U.S. FDA’s “archaic view” of testing is impeding the use of paper strip tests he said would turn the tide in the effort to contain the pandemic. Read More
Coronavirus-pandemic2

Neura sees the adoption of the Viruscore predictive testing solution

Neura Inc., which focuses on AI-powered behavioral intelligence that provides real-world insights for health organizations, governments and consumer brands, has revealed the adoption of its Viruscore COVID-19 predictive testing solution. Read More
Heart.png

NMPA approves the first AI ECG diagnostic machine

HONG KONG – A Chinese med-tech company plans to take to market what it claims is the first electrocardiography (ECG) diagnostic machine powered by AI, but as it moves to markets beyond China, it could face significant competition. Read More
Mouse breast cancer cells

Study links mitochondrial DNA to abscopal response

Investigators at Weill Cornell Medical College have demonstrated that mitochondrial DNA drives the abscopal antitumor response to radiation, which can be boosted by autophagy inhibition. Read More

Appointments and advancements for Aug. 7, 2020

New hires and promotions in the med-tech industry, including: Atricure, Cutera, Halberd, Florence Healthcare, Pacific Biosciences of California, Pulse Biosciences. Read More

Financings for Aug. 7, 2020

Med-tech firms raising money in public or private financings, including: Avinger, Innovheart, Quanterix. Read More

In the clinic for Aug. 7, 2020

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Caption Health. Read More

Med-tech gainers and losers for Aug. 3-7, 2020

The top 10 med-tech stock gainers and losers for the week. Read More

Other news to note for Aug. 7, 2020

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Arc Medical Design, Anpac Bio-Medical Science, BBS-Bioactive Bone Substitutes, Bruker, Establishment Labs Holdings, Highmark, Mdxhealth, Norgine Orion Trading, Olympus, Sbl Technologies, Senseonics, Sparta, Todos Medical. Read More

Regulatory actions for Aug. 7, 2020

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Co-Diagnostics, Guardant Health, Scientia Vascular. Read More

Regulatory front for Aug. 7, 2020

The latest global regulatory news, changes and updates affecting medical devices and technologies, including: MITA. Read More

BioWorld MedTech’s Neurology Extra for Aug. 7, 2020

Keeping you up to date on recent developments in neurology, including: Brain computer improves function in paralyzed patient; Blood test could diagnose brain damage hours after birth; Power-saving, wireless neural implant developed; After injury, astrocytes can make interneurons. Read More

BioWorld MedTech Patent Highlights: Week 31

BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette. Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 24, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 24, 2025.
  • Illustration of magnifying glass looking at cancer in the brain

    Researchers discover how glioblastoma tumors dodge chemotherapy

    BioWorld MedTech
    Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
  • Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

    HIV research is close to a cure but far from ending the pandemic

    BioWorld
    Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
  • Illustration of tau accumulating in a neuron cell.

    ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug

    BioWorld
    ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing